Clinical trial
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease…
NCT00167583 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00167583 |
|---|---|
| Title | Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) |
| Official title | Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet's Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB) |
| Acronym | INCYTOB |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Behcet's Disease, Panuveitis, Posterior Uveitis, Retinal Vasculitis |
| Intervention type | Drug |
| Interventions | Cyclosporin A, Interferon-alpha2a |
| Enrollment | 37 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Sep 14, 2005 |
| Last update posted | May 17, 2018 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: